Cellerix is a biotechnology company developing therapies based on adult stem cells.
Business Model:
Revenue: $10M
Employees: 2-10
Address:
City: Madrid
State: Madrid
Zip:
Country: Spain
Cellerix, S.A., a biotechnology company, engages in the development and production of medicines based on the use of stem cells of adult origin. The company offers products for the treatment of gastroenterology, dermatology, and immune-based diseases. Its products include Cx401, which is used for the treatment of complex perianal fistulas; and Cx501, a cell therapy product to be applied in the treatment of Epidermolysis Bullosa. Cellerix, S.A. was founded in 2004 and is based in Tres Cantos, Spain.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2009 | Series B | 6 | $40.5M |
Biopartners Capital EQT life science Novartis Venture Fund Roche Venture Fund Ventech Ysios Capital Biopartners Capital EQT life science Novartis Venture Fund Roche Venture Fund Ventech Ysios Capital |
9/2007 | Series B | 5 | $37.2M |
EQT life science Novartis Venture Fund Roche Venture Fund Ventech Ysios Capital EQT life science Novartis Venture Fund Roche Venture Fund Ventech Ysios Capital |
1/2010 | Series C | 6 | $37.7M |
EQT life science Grupo Genetrix Novartis Venture Fund Roche Venture Fund Ventech Ysios Capital EQT life science Grupo Genetrix Novartis Venture Fund Roche Venture Fund Ventech Ysios Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|